Allworth Financial’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $444 | Buy |
19
+13
| +217% | +$304 | ﹤0.01% | 4158 |
|
|
2025
Q1 | $339 | Sell |
6
-14
| -70% | -$791 | ﹤0.01% | 3766 |
|
|
2024
Q4 | $283 | Hold |
20
| – | – | ﹤0.01% | 3719 |
|
|
2024
Q3 | $222 | Hold |
20
| – | – | ﹤0.01% | 3580 |
|
|
2024
Q2 | $248 | Hold |
20
| – | – | ﹤0.01% | 3521 |
|
|
2024
Q1 | $655 | Hold |
20
| – | – | ﹤0.01% | 3210 |
|
|
2023
Q4 | $535 | Hold |
20
| – | – | ﹤0.01% | 3114 |
|
|
2023
Q3 | $1.21K | Hold |
20
| – | – | ﹤0.01% | 2767 |
|
|
2023
Q2 | $2.04K | Hold |
20
| – | – | ﹤0.01% | 2476 |
|
|
2023
Q1 | $3.53K | Sell |
20
-1
| -5% | -$177 | ﹤0.01% | 2177 |
|
|
2022
Q4 | $8.04K | Buy |
21
+1
| +5% | +$383 | ﹤0.01% | 1751 |
|
|
2022
Q3 | $7K | Hold |
20
| – | – | ﹤0.01% | 1799 |
|
|
2022
Q2 | $7K | Hold |
20
| – | – | ﹤0.01% | 1683 |
|
|
2022
Q1 | $9K | Sell |
20
-1
| -5% | -$450 | ﹤0.01% | 1527 |
|
|
2021
Q4 | $9K | Hold |
21
| – | – | ﹤0.01% | 1436 |
|
|
2021
Q3 | $12K | Hold |
21
| – | – | ﹤0.01% | 1250 |
|
|
2021
Q2 | $11K | Hold |
21
| – | – | ﹤0.01% | 1032 |
|
|
2021
Q1 | $17K | Buy |
21
+1
| +5% | +$810 | ﹤0.01% | 843 |
|
|
2020
Q4 | $11K | Hold |
20
| – | – | ﹤0.01% | 827 |
|
|
2020
Q3 | $9K | Hold |
20
| – | – | ﹤0.01% | 751 |
|
|
2020
Q2 | $12K | Hold |
20
| – | – | ﹤0.01% | 691 |
|
|
2020
Q1 | $9K | Hold |
20
| – | – | ﹤0.01% | 735 |
|
|
2019
Q4 | $12K | Hold |
20
| – | – | ﹤0.01% | 618 |
|
|
2019
Q3 | $13K | Hold |
20
| – | – | ﹤0.01% | 537 |
|
|
2019
Q2 | $15K | Hold |
20
| – | – | ﹤0.01% | 517 |
|
|
2019
Q1 | $14K | Buy |
20
+4
| +25% | +$2.8K | ﹤0.01% | 523 |
|
|
2018
Q4 | $8K | Hold |
16
| – | – | ﹤0.01% | 566 |
|
|
2018
Q3 | $14K | Hold |
16
| – | – | ﹤0.01% | 506 |
|
|
2018
Q2 | $11K | Buy |
+16
| New | +$11K | ﹤0.01% | 519 |
|